Estimating the IFR for global populations helps to identify relative vulnerabilities to COVID-19. Information about how IFR varies by age, time, and […]
Garadacimab 200 mg and 600 mg every 4 weeks significantly reduced the number of monthly attacks versus placebo and was well tolerated […]
As we found no clear differences between antipsychotics for relapse prevention, we conclude that the choice of antipsychotic for maintenance treatment should […]
Experts warn of huge global inequities in access to new treatments for COVID-19. Ann Danaiya Usher reports.
Cancer affects everyone, regardless of age, gender, or social status, and represents a tremendous burden for patients, families, and societies. In 2020, […]